Clinical trial
CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic…
NCT00075647 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00075647 |
|---|---|
| Title | CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer |
| Official title | Phase II Trial of CCI-779 in Locally Advanced or Metastatic Pancreatic Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer |
| Intervention type | Drug, Other |
| Interventions | temsirolimus, laboratory biomarker analysis |
| Enrollment | 40 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 1, 2005 |
| First posted | Jan 12, 2004 |
| Last update posted | Jan 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: